Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients can ...

Type 2 diabetes patients on GLP-1 treatments, such as Ozempic, have a lower risk of 10 obesity-related cancers compared to those on insulin and other drugs, according to a new study. GLP-1 treatments ...

A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ...

Diabetes rates continue to rise. Scientists have now created a pain-free drug delivery method to help people with diabetes manage the disease and maintain their health more easily. Researchers have ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it. Objective: To examine the ...

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a Phase 1/2 study. Genetically engineered islet cells with immune evasion ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...

Patients with severe insulin resistance may benefit from concentrated insulin. Patients with type 2 diabetes and severe insulin resistance may require large doses of insulin to achieve glycemic ...

* First-ever human transplant of gene-edited insulin-producing cells without immune rejection * Patient produced natural insulin for 12 weeks with no //immunosuppressants * Marks a breakthrough step ...

Please provide your email address to receive an email when new articles are posted on . Of 11,758 patients with CKD, diabetes and hypertension in the study, researchers found 1,285 cases of dementia.